JOHN B GREEN Insider Trading
Get free email notifications about insider trading for JOHN B GREEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN B GREEN. JOHN B GREEN is a Senior Vice President and CFO in rEVO Biologics, Inc. ($GTCB) and a Senior VP and CFO in rEVO Biologics, Inc. ($GTCB) and a SVP and CFO in rEVO Biologics, Inc. ($GTCB) and a Chief Financial Officer in Dicerna Pharmaceuticals Inc ($DRNA) and a Chief Financial Officer in Verastem, Inc. ($VSTM).
Address: C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM 01702 MA
Companies in which JOHN B GREEN is an Insider
Dicerna Pharmaceuticals Inc
Trading Symbol: DRNAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN B GREEN: Chief Financial Officer
Holdings: 45,045 shares
Current Value: $116,216
Latest Transaction: Apr 22 2020
$DRNA Market Capitalization: $50.84M
$DRNA Previous Close: $2.58
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
rEVO Biologics, Inc.
Trading Symbol: GTCBIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN B GREEN: Senior VP and CFO, SVP and CFO, Senior Vice President and CFO
Holdings: 28,173 shares
Latest Transaction: Nov 04 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verastem, Inc.
Trading Symbol: VSTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN B GREEN: Chief Financial Officer
Holdings: 2,500 shares
Current Value: $3,100
Latest Transaction: Jan 04 2016
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN B GREEN
Sentiment: All, DRNA, GTCB, VSTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2020 | DRNA | Dicerna Pharmaceut ... | GREEN JOHN B | Chief Financial Off ... | Option Exercise | M | 5.45 | 25,624 | 139,651 | 186,375 | |
Apr 22 2020 | DRNA | Dicerna Pharmaceut ... | GREEN JOHN B | Chief Financial Off ... | Sell | S | 22.95 | 25,624 | 588,071 | 19,421 | 45 K to 19.4 K (-56.89 %) |
Apr 22 2020 | DRNA | Dicerna Pharmaceut ... | GREEN JOHN B | Chief Financial Off ... | Buy | M | 5.45 | 25,624 | 139,651 | 45,045 | 19.4 K to 45 K (+131.94 %) |
Apr 22 2020 | DRNA | Dicerna Pharmaceut ... | GREEN JOHN B | Chief Financial Off ... | Option Exercise | M | 5.45 | 25,624 | 139,651 | 186,375 | |
Apr 22 2020 | DRNA | Dicerna Pharmaceut ... | GREEN JOHN B | Chief Financial Off ... | Sell | S | 22.95 | 25,624 | 588,071 | 19,421 | 45 K to 19.4 K (-56.89 %) |
Apr 22 2020 | DRNA | Dicerna Pharmaceut ... | GREEN JOHN B | Chief Financial Off ... | Buy | M | 5.45 | 25,624 | 139,651 | 45,045 | 19.4 K to 45 K (+131.94 %) |
Apr 09 2020 | DRNA | Dicerna Pharmaceut ... | GREEN JOHN B | Chief Financial Off ... | Option Exercise | M | 2.97 | 12,968 | 38,515 | 14,063 |